- Email: [email protected]
Quality of Life and Health Status After Chinese Herb Treatment in Stable Angina Patients
October 2012, Vol 142, No. 4_MeetingAbstracts Cardiovascular Disease | October 2012
Quality of Life and Health Status After Chinese Herb Treatment in Stable Angina Patients Shihan Wang*, MD; Ji Li, MD; Xingjiang Xiong, MD; Yong Ye, MD; Qingyong He, MD; Jie Wang, MD Guang An Men Hospital, China Academy of Chinese Medical Science, Beijing, China
Chest. 2012;142(4_MeetingAbstracts):85A. doi:10.1378/chest.1389601
Abstract SESSION TYPE: Arrhythmia and Coronary Artery Disease PRESENTED ON: Monday, October 22, 2012 at 11:15 AM - 12:30 PM PURPOSE: To evaluate the long term quality of life and health status in patients with stable angina after Chinese herb (made from Chinese sage and trichosanthes) treatment. METHODS: We performed a prospective multi-center placebo controlled trial to evaluate the long term quality of life after Chinese herb treatment. The Chinese herb are made from Chinese sage and trichosanthes. All the patients got standardized therapy included Aspirin, simvastatin and isosorbide dinitrate according to the guideline for the management of stable angina. On the top of these standardized treatments, 66 patients got Chinese herb treatment and the
other half got placebo. All patients were followed up for one year. The primary outcome was the change of SF-36 and Seattle Angina Questionnaire (SAQ). RESULTS: A total of 132 patients from four participated centers were enrolled in the study from 2008 to 2009. No significant differences were observed in the baseline characteristics and comorbidities between two groups. The mean age is 61±9 in herb group vs. 62±8 in placebo controls, 74% male versus 72%, hypertension present 50% vs. 61% and hyperlipedimia 32% vs. 30% ,respectively. The score of short form-36 (SF-36) increased significantly from 58±10 to 77±15 (P<0.01) in herb treatment group but no significant increase in control group from 58±11 to 67±12(p=0.09). The SAQ score increased significantly after one year treatment in both groups. While the increase of SAQ is significantly higher in herb treatment group (35±15)when compared to the placebo controls (15±10). CONCLUSIONS: The Chinese herb treatment can significantly improve the quality of life in the stable angina patients when compared to placebo controls as assessed by SF-36 and SAQ. CLINICAL IMPLICATIONS: This trial indicates that integrated therapy included both Chinese Herb and standardized western medicine can improve one year health status of stable angina patients. The nature herb should be considered as an important adjutant therapy for stable angina patients. DISCLOSURE: The following authors have nothing to disclose: Shihan Wang, Ji Li, Xingjiang Xiong, Yong Ye, Qingyong He, Jie Wang No Product/Research Disclosure Information Guang An Men Hospital, China Academy of Chinese Medical Science, Beijing, China
Quality of Life and Health Status After Chinese Herb Treatment in Stable Angina Patients Shihan Wang*, MD; Ji Li, MD; Xingjiang Xiong, MD; Yong Ye, MD; Qingyong He, MD; Jie Wang, MD Guang An Men Hospital, China Academy of Chinese Medical Science, Beijing, China
Chest. 2012;142(4_MeetingAbstracts):85A. doi:10.1378/chest.1389601
Abstract SESSION TYPE: Arrhythmia and Coronary Artery Disease PRESENTED ON: Monday, October 22, 2012 at 11:15 AM - 12:30 PM PURPOSE: To evaluate the long term quality of life and health status in patients with stable angina after Chinese herb (made from Chinese sage and trichosanthes) treatment. METHODS: We performed a prospective multi-center placebo controlled trial to evaluate the long term quality of life after Chinese herb treatment. The Chinese herb are made from Chinese sage and trichosanthes. All the patients got standardized therapy included Aspirin, simvastatin and isosorbide dinitrate according to the guideline for the management of stable angina. On the top of these standardized treatments, 66 patients got Chinese herb treatment and the
other half got placebo. All patients were followed up for one year. The primary outcome was the change of SF-36 and Seattle Angina Questionnaire (SAQ). RESULTS: A total of 132 patients from four participated centers were enrolled in the study from 2008 to 2009. No significant differences were observed in the baseline characteristics and comorbidities between two groups. The mean age is 61±9 in herb group vs. 62±8 in placebo controls, 74% male versus 72%, hypertension present 50% vs. 61% and hyperlipedimia 32% vs. 30% ,respectively. The score of short form-36 (SF-36) increased significantly from 58±10 to 77±15 (P<0.01) in herb treatment group but no significant increase in control group from 58±11 to 67±12(p=0.09). The SAQ score increased significantly after one year treatment in both groups. While the increase of SAQ is significantly higher in herb treatment group (35±15)when compared to the placebo controls (15±10). CONCLUSIONS: The Chinese herb treatment can significantly improve the quality of life in the stable angina patients when compared to placebo controls as assessed by SF-36 and SAQ. CLINICAL IMPLICATIONS: This trial indicates that integrated therapy included both Chinese Herb and standardized western medicine can improve one year health status of stable angina patients. The nature herb should be considered as an important adjutant therapy for stable angina patients. DISCLOSURE: The following authors have nothing to disclose: Shihan Wang, Ji Li, Xingjiang Xiong, Yong Ye, Qingyong He, Jie Wang No Product/Research Disclosure Information Guang An Men Hospital, China Academy of Chinese Medical Science, Beijing, China